While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of ...
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
Idaho Sen. Brandon Shippy proposes bill to ban mRNA vaccines until 2035 by incorrectly categorizing them as gene therapy, ...
Newly released FDA emails reveal inconsistent monitoring of COVID-19 vaccine injuries, with frequent alerts for the Janssen vaccine but few for Pfizer and Moderna. Despite over 1.4 million adverse ...
SINGAPORE - People who are eligible for the Novavax Covid-19 vaccine can go to selected clinics from Jan 24 to April 30 for ...
Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...
Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...